Clinical Trial Update: Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing two growth hormone dosing methods in adults with hypopituitarism-related growth hormone deficiency. Sponsored by Eli Lilly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Hypopituitarism

Drugs mentioned

• HUMATROPE (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypopituitarism | Phase 4 | Status: COMPLETED